PanKind announces the recipients of over $2.25 million of grant funding to progress pancreatic cancer research in the key areas of Early Detection and New Treatments.
Read story ➞The 2024 PanKind Scientific Meeting gathered over 120 brilliant minds to share advancements and insights in pancreatic cancer research. Sessions covered topics from new therapies to early detection, all with a central goal: improving patient outcomes.
Read story ➞November is recognised globally as Pancreatic Cancer Awareness Month and is an important time of year for communities to raise awareness of the disease, celebrate survivors and honour loved ones.
Read story ➞